Methotrexat Accord

Methotrexate, the active ingredient in Methotrexat Accord, is an antimetabolite (folate antagonist) presented as a sterile solution for intraarterial, intramuscular, and intravenous use. It is employed to treat rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, non‑Hodgkin lymphoma and breast cancer in appropriate patients.

GNH USA supplies Methotrexat Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Methotrexat Accord is used across several disease families where inhibition of folate metabolism is therapeutic. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: diminishes skin plaque formation and severity. - Acute lymphoblastic leukemia: interferes with malignant cell proliferation. - Non‑Hodgkin lymphoma: induces tumor cell death. - Breast cancer: acts as an adjuvant to limit tumor growth.

Methotrexat Accord may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea and vomiting: gastrointestinal upset occurring shortly after administration. - Fatigue: persistent tiredness not relieved by rest. - Oral mucositis: painful sores or ulcers in the mouth. - Elevated liver enzymes: mild hepatic irritation detected in laboratory tests. - Cytopenias: reduced white blood cells, red blood cells, or platelets.

Serious or Rare Side Effects: - Severe hepatotoxicity: significant liver injury requiring monitoring. - Pulmonary fibrosis: progressive scarring of lung tissue. - Life‑threatening infection: due to profound immunosuppression. - Bone marrow failure: aplastic anemia with pancytopenia. - Renal toxicity: impaired kidney function. - Secondary malignancies: rare development of new cancers.

Before initiating therapy, several safety considerations are recommended. - Monitor liver function: perform baseline and periodic liver enzyme tests. - Assess blood counts: regular complete blood count to detect cytopenias. - Avoid in pregnancy: teratogenic risk requires effective contraception. - Adjust for renal impairment: dose modification may be needed in reduced kidney function. - Use contraception: both male and female patients should employ reliable birth control. - Store at ambient temperature: keep in original container, protect from moisture and light.

Methotrexat Accord can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Trimethoprim‑sulfamethoxazole: may potentiate bone‑marrow suppression. - Live vaccines: risk of uncontrolled infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Azathioprine: additive immunosuppressive effect, monitor blood counts. - Cyclosporine: may raise methotrexate plasma levels, adjust dose as needed. - Phenytoin: can reduce methotrexate clearance, watch for reduced efficacy.